How does sharewise work?
Discuss
Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard
Show moreTop Buy/Sell (This Month)
| Security | Price | Target price |
|---|---|---|
| Microsoft Corp. | €416.20 | €500.91 |
| Amazon.com Inc. | €224.25 | €258.70 |
| Alphabet Inc. C | €295.05 | €367.50 |
| Security | Price | Target price |
|---|---|---|
| Clorox Co. | €91.40 | €91.19 |
| Western Union Co. | €6.23 | €6.07 |
| Axt Inc. | €71.14 | €60.00 |
New Top predictions since last week
| Prediction | User | Perf. (%) |
|---|---|---|
| B Tvardi Therapeutics Inc. | quelbe60 | 39.42% |
| B EyePoint Pharmaceuticals Inc. | Kryptonit | 22.92% |
| B EyePoint Pharmaceuticals Inc. | Chardan Capital | 19.80% |
| Prediction | User | Perf. (%) |
|---|---|---|
| S Capricor Therapeutics Inc | Bankster | -22.55% |
| S Socket Mobile Inc. | blaugold | -18.52% |
| S Applied Optoelectronics Inc. | Bankster | -14.97% |
Many tell you which stocks to buy.
We measure how often they are right!
Portfolios of our members
OP Research
When it comes to stocks, what is important for you?
Find stocks based on your criteria with our sharewise stock finder. All results are based on thousands of votes by our community
Pros and Cons of these stocks (New Predictions)
EyePoint Pharmaceuticals Inc.
WKN: A2QJRU / Symbol: EYPT / Name: EyePoint Pharma / Stock / Biotechnology & Medical Research / Small Cap /
Pros
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!Tops & Flops S&P 500
| Security | Price | Change(%) (%) |
|---|---|---|
| Targa Resources Corp. | €257.30 | 7.500% |
| Bath & Body Works Inc. | €17.33 | 6.840% |
| Insulet Corp. | €128.00 | 5.970% |
| Carnival Paired Ctf | €23.45 | 5.850% |
| Discovery Communications C | €22.42 | 5.110% |
| Security | Price | Change(%) (%) |
|---|---|---|
| Ciena Corp. | €350.10 | -10.120% |
| Lumentum Holdings Inc | €754.20 | -9.910% |
| Teradyne Inc. | €348.75 | -9.360% |
| Sandisk Corp. | €1,410.0 | -9.030% |
| Seagate Technology.Holdings plc | €782.00 | -8.600% |
Courses
Get started on the stock market in these easy steps
Things you will learn:
- What is a stock
- What is a fund
- What is an ETF
- How to open a depot
- How to manage a depot that will regularly beat managed funds
- Why you mostly need patience to succeed on the stock market
sharewise Introduction
Predictions
EyePoint Pharmaceuticals Inc.
18.08.26
18.08.27
14.08.26
Top News
Crexendo Nears $100M Run Rate as ESI, AI and Wholesale Wins Fuel Growth
Key Points
- Interested in Crexendo Inc.? Here are five stocks we like better.
- Crexendo is nearing a $100 million annualized revenue run rate after reporting quarterly revenue of $24.6 million
Corporacion America Airports Q2 Earnings Call Highlights
Key Points
- Interested in Corporacion America Airports S.A.? Here are five stocks we like better.
- Second-quarter adjusted EBITDA excluding IFRIC 12 fell 4.5% to $160 million, as weaker Argentine
The AI Boom Is Turning This Cable Maker Into a Stock to Watch
Key Points
- Interested in Belden Inc? Here are five stocks we like better.
- Belden is not a chipmaker, but its connectivity products are becoming more relevant as AI data centers expand.
- The
APA Targets $700M Cost Cuts, 5% Oil Growth as Suriname Project Nears 2028 Start
Key Points
- Interested in APA Corporation? Here are five stocks we like better.
- APA expects roughly $700 million in lower annual cash costs by 2027, including $500 million in structural savings
A Star Investor Just Trimmed Amazon—Here's What It means
Key Points
- Interested in Amazon.com, Inc.? Here are five stocks we like better.
- Dan Loeb's Third Point trimmed its Amazon stake by roughly 10%, but the fund still holds it as a top position
Value Investors: Waiting for the Fat Pitch
Welcome to Episode #451 of the Value Investor Podcast.
Every week, Tracey Ryniec, the editor of Zacks Value Investor portfolio, shares some of her top value investing tips and stock picks.
On Aug
Top Analyst Reports for Visa, Lam Research & Caterpillar
Tuesday, August 18, 2026The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Visa Inc.
The Best "Strong Buy" Stocks to Buy Now and Heading into September
The S&P 500 and the Nasdaq dropped on Tuesday. Wall Street used headlines about Iran and rising bond yields as reasons to start taking profits on the array of stocks that had skyrocketed off their
U.S.-China 2026 Tech Race: 2 AI Stocks & 2 Quantum Stocks to Watch
The U.S.-China technology race is increasingly becoming a contest over artificial intelligence, quantum computing, semiconductors, critical minerals and control of strategic technology supply
News
Ecolab's CoolIT Deal Raises AI Upside but Also Debt and Cost Risks
Ecolab Inc. ECL has expanded its artificial intelligence infrastructure exposure with the $4.75 billion acquisition of CoolIT Systems. The deal gives Ecolab a larger role in data-center cooling as
Is Ecolab Stock Worth Buying as Growth Rises but Debt Risk Builds?
Ecolab Inc. ECL is delivering faster growth across High-Tech, Digital and Life Sciences while pricing and productivity support profitability. The question for investors is whether those improving
Digital Turbine Jumps 208% in a Year: Is the Stock Worth Buying Now?
Shares of Digital Turbine Inc. APPS have risen a whopping 208.3% over the past year, outperforming the Zacks Internet – Software industry's decline of 10%. The company has also outpaced the Computer
Ecolab Rallies 12.2% in 3 Months as High-Tech Growth Gains Momentum
Ecolab Inc. ECL shares have gained 12.2% over the past three months, drawing attention to whether improving operating momentum can sustain the advance.
Faster growth in High-Tech, Digital and Life
Is Gilead's Expanding HIV Portfolio a Growth Catalyst?
Gilead Sciences, Inc. GILD has a market-leading HIV franchise, led by flagship HIV therapies — Biktarvy for treatment and Descovy for prevention.
Earlier this month, the company reported
VF Corp. Raises Fiscal 2027 Sales Outlook as Outdoor Growth Offsets Vans
VF Corporation VFC raised its fiscal 2027 constant-currency revenue outlook to growth of 2% or better, up from its previous 1-2% range, after first-quarter performance exceeded management’s revenue
SBH Q3 Results Pair Margin Gains With a Tighter 2026 Sales Outlook
Sally Beauty Holdings, Inc. SBH posted fiscal third-quarter 2026 adjusted earnings of 55 cents per share, beating the Zacks Consensus Estimate of 53 cents. Net sales edged up 0.2% to $935.5 million
Contest
Still running
Leeway
Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.
Heibel Ticker
sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.